Fairfield, Bush & Co’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$269K Sell
2024
Q2
$325K Buy
2024
Q1
$343K Buy
2023
Q4
$136K Buy
2023
Q3
Sell
2023
Q2
$289K Hold
2023
Q1
$233K Buy
2022
Q3
Sell
2022
Q2
$36K Buy
2021
Q4
Sell
2021
Q3
$386K Buy